KEY MESSAGES
Health system decentralization presents a challenge to the integration of Global Fund-supported programmes in Indonesia, where HIV and TB programmes are largely vertical.
Temporary suspension of Global Fund support in 2008 has increased awareness of stewardship and governance practices.
Global Fund investment has freed up national resources for other priorities, although this hinders the development of an exit strategy.
Background
Indonesia is a lower-middle-income country in South-East Asia. With a population of over 222 million, it is the most populous Muslim-predominant country in the world and is ethnically diverse (SEARO 2009 ). Indonesia has significant geographical challenges that impact on healthcare; it spans a total land area of over 1.8 million km 2 , consists of over 17 000 islands and is prone to major earthquakes and volcano eruptions. Since 2001, there has been decentralization of government authorities, impacting the health system. Central government has overall regulatory function but responsibilities for planning, financing and distribution of services lie with local governments (World Bank 2008) .
Similar to other lower-middle-income countries, Indonesia faces the dual challenge of communicable and non-communicable disease morbidity and mortality. The HIV epidemic in Indonesia is concentrated among injecting drug users (IDU) and sex workers; however, there is a generalized epidemic in Papua province. Although national HIV prevalence is still low (0.16%), there has been a rapid increase in reported cumulative AIDS cases, making the epidemic in Indonesia one of the fastest growing in Asia (SEARO 2007) . Indonesia has had a National AIDS Strategy since 1995, but financing was initially affected by the economic crisis. There has been recent political commitment by the President to AIDS, with reinforcement and restructuring of the National AIDS Commission and a step-up in the responses to HIV/AIDS. The government contributes approximately 30% of funds for AIDS programmes, the remainder comes from bilateral donors and Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund).
Indonesia has the third highest prevalence of tuberculosis (TB) infection in the world with multi-drug resistant TB being a major challenge (WHO 2008) . Co-infection rates of TB with HIV infection are estimated to be low but there is no formal surveillance programme. The National TB Programme (NTP) has been long established, with directly observed treatment (DOT) coverage of 98% in 2006 98% in (WHO 2008 .
Indonesia has been successful in securing Global Fund funding in several rounds, accumulating an approved maximum of more than US$331 million (Table 1) . This equates to an annual average disbursement of US$11.5 million to TB, US$10 million to malaria and US$8.3 million to HIV/AIDS. However, there was suspension of Global Fund funding in Indonesia in 2008 due to concerns about governance and conflict of interest.
Methods
The study design was based on that described for a Vietnam case study in Conseil et al. (2010) , with the analytical framework and toolkit extended to assess not only the integration of the national HIV and TB programmes with the general health system, but also the integration of Global Fund HIV and TB portfolios within their respective disease programmes, and any system-wide effects of Global Fund support. As in Conseil et al. (2010) , data were collected through a literature review and the use of the Systemic Rapid Assessment Toolkit (SYSRA) for gathering information about structures and modes of operation of complex health systems (Atun et al. 2004; Atun et al. 2010) . Primary data were collected through qualitative interviews using a semi-structured interview topic guide designed as part of the SYSRA, conducted during August 2009. Overall, 22 interviews were conducted with government health officials, partners and civil society actors at national, regional and district levels, both within the disease programmes and in the general health care system. All interviews were conducted within Jakarta Province.
Full details of data analysis can be found in Conseil et al. (2010) . Briefly, the six health system functions proposed by the SYSRA framework (stewardship and governance, financing, planning, service delivery, monitoring and evaluation, and demand generation) were subdivided into 25 elements (as defined in Table 2 ), for which we classified the level of integration as 'not integrated', 'partly integrated' or 'fully integrated', through iterative analysis and triangulation of the collected data. Classification of the level of integration was agreed upon by two staff of the London School of Hygiene & Tropical Medicine, one of whom was also an assessor across three other case studies presented in this supplement, to ensure consistency.
Results and discussion

Integration
The Global Fund programmes in Indonesia are highly vertical and centralized, which is in contrast and sometimes in conflict with the decentralized nature of the Indonesian health system. As a result, there is generally more integration of all functions, particularly planning and service delivery, at local levels compared with centrally. There is a concern about ensuring sustainability of programmes and an exit strategy from donor funding. A strategy has been built into the National AIDS Programme, and other donors have tried to encourage a i44 HEALTH POLICY AND PLANNING disengagement strategy from donor funding. However, there are concerns at both local and national level that this could be jeopardized by shifting of government resources earmarked for HIV and TB into other disease and non-disease programmes that require additional funding.
Despite these concerns, there is a high level of integration of the Global Fund HIV and TB portfolios into the National AIDS and TB Programmes (Table 2) in terms of planning, with the establishment of the National AIDS Commission (NAC) and the National TB Programme, which have overall responsibility for their programmes. There is partial integration of these programmes with other programmes and the general health system (Table 2 ). For example, there are formal joint working groups for planning activities for HIV and maternal health, and decisions are incorporated into planning documents of both disease programmes with clear lines of action.
Both HIV and TB programmes use Global Fund funding to fill gaps in financing of their programmes at the national level. However, as Global Fund funding is vertical and strictly earmarked, gaps at the local level must be filled under the decentralized government structure. In practice, this involves the shifting of resources between disease programmes. Furthermore, this structure does not take into account changing demands on services due to changes in epidemiology and demand generation.
At both the national and local levels, staff for the AIDS and TB programmes are recruited through the Ministry of Health (MoH) system and receive incentive payments from the Global Fund. However, concern was expressed that this system attracts health care workers away from non-Global Fund funded projects, resulting in staff shifting, even within the same disease programme. The picture is less distinct at local level, where the nature of health care provision means that TB and HIV staff tend to care for patients under both the MoH and Global Fund schemes, as well as patients with other diseases. Training for HIV and TB health care workers, despite being coordinated by the MoH, is specific for these two diseases, with limited skill-specific modules that overlap other diseases, such as behaviour change and monitoring and evaluation (M&E). This provision of specific training is a further staff incentive.
This coordinated approach is applied to procurement of drugs at the local levels, but less so at national level, where drug procurement and supply of Global Fund funded drugs is separate from that of MoH-procured drugs for HIV and TB. This is in part due to Indonesian pharmaceutical companies not being WHO pre-registered.
There is partial integration of stewardship and governance functions of Global Fund programmes and the disease programmes. For example, both the MoH and the Secretariat of the NAC are represented on the Country Coordinating Mechanism for Global Fund programmes. In 2008 there was temporary suspension of Global Fund financing due to concerns about a conflict of interest within the Country Coordinating Mechanism (CCM). In response, there has been greater awareness of governance and stewardship; for example, an Oversight and Scrutiny Committee has been formed, which also has MoH representation.
Despite some integration of other functions, there is no integration of M&E for the Global Fund HIV and TB portfolios within the national AIDS and TB programmes; each has different indicators and reporting systems.
System-wide effects
There have been several system-wide effects, both benefits and unintended consequences of Global Fund investment. As a consequence of the temporary suspension of Global Fund funding in 2008, several respondents felt that there is generally increased awareness of good governance practice within the MoH. However, this mechanism does not appear to have been formally carried over to the general health care system. Some stakeholders also felt that Global Fund support has freed up Table 2 Extent of integration of Global Fund portfolios for HIV and TB into the disease programmes, and the disease programmes into the general health system, for each health system element and function in Indonesia
Key:
This element is fully or predominantly integrated into the general health system, i.e. this element is (quasi) exclusively under the management and control of the general health care system. This element is partially integrated into the health system or; this element is integrated in some but not all cases, i.e. this element is managed and controlled both by the general health care system and a specific programme-related structure.
This element is not, or only to a very limited extent, integrated into the health system as a whole, i.e. this element is (quasi) exclusively under the management and control of a specific programme-related structure which is distinct from the general healthcare system.
Does not apply. n.a. investment for other disease and non-disease programmes that require extra investment, particularly at local levels. However, this is not beneficial to ensuring a robust exit strategy from Global Fund support in the long term.
In terms of service delivery, monetary incentives provided under the Global Fund programmes for staff working on HIV and TB may have had some unintended consequences. This incentivization is not carried over to other disease programmes, and there were reports of staff shifting towards the HIV and TB programmes away from other programmes such as health promotion.
Finally, there has been increased awareness of co-infection and the need to integrate programme planning, financing and service delivery to avoid duplication and for a coordinated response. This relates not only to HIV-TB co-infection, but has been recognized for other diseases, such as TB-leprosy.
Policy implications for the Global Fund
Our analysis shows that there have been some wider benefits from Global Fund support, in particular in allowing an integrated approach to planning HIV and TB services, increasing service provision and demand generation. At local levels, due to the more integrated nature of health care provision, there has been greater integration of Global Fund funding with disease programmes.
However, there have been several unintended consequences that form the basis of policy recommendations for the Global Fund. The conflict between the verticality of Global Fund funding and the decentralized nature of the Indonesian health system has resulted in reduced integration of financing, service delivery, demand generation and M&E. As a result, there should be more alignment of the vertical nature of Global Fund funding with the decentralized nature of the Indonesian health system, with flexibility in funding allocations to respond to the changing epidemiology of the diseases and changing needs. The introduction of non-governmental organizations as Principal Recipients of Global Fund grants may help facilitate this. Furthermore, concerns expressed by respondents regarding sustainability of the programmes, along with reports of shifting of government resources to other diseases or non-disease programmes requiring additional funding, highlights the need for an exit/sustainability strategy at both national and local level for the Global Fund programmes.
Reports of staff shifting to Global Fund programmes due to incentive payments and training opportunities may suggest a threat of staff shortages in other disease programmes. The potential impact of incentive payments in terms of staff imbalances therefore requires further assessment, and the possibility of offering wider access to training for all staff could also be evaluated.
There is already greater awareness of governance and stewardship mechanisms within the MoH following temporary suspension of Global Fund funding in 2008 and this has begun to have a system-wide impact. However, there is a need for increased capacity building support for the Country Coordinating Mechanism and continued support for the governance structure.
Several stakeholders noted the need for increased collaboration between partners to ensure a coordinated response. Global Fund should consider formulation of subsidiary agreements with other donors to ensure a coordinated response to HIV and TB, and there needs to be increased partnership with non-governmental organizations and other donor organizations, and more engagement with the private sector. Alignment of the M&E systems for the Global Fund, other donors and the general health system should be considered in order to ultimately create a single robust and integrated system.
